共 24 条
[1]
AntiHIV-1 and anti-HIV-1 protease substances from Ganoderma lucidum. El-Mekkawy S,Meselhy MR,Nakamura N,et al. Phytochemistry . 1998
[2]
Effects of triterpenoids from Ganoderma lucidum ( leyss. Ex fr. ) Karst on three different experimental liver injury models in mice. Wang MY,Liu Q,Che QM,et al. Acta Pharm Sin (药学学报) . 2000
[3]
Angiotensin converting enzyed-inhititory triterpense from Ganoderma lucidum. Morigiwa A,Kitabatake K,Fujimoto Y,et al. Chemical and Pharmaceutical Bulletin . 1986
[4]
Application of NMR techniques in the structure determination of ganosporelactone A and B. Chen RY,Yu DQ. Acta Pharm Sin (药学学报) . 1991
[5]
Divalent cation and prenyl pyrophosphate specidicities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme. Reiss Y,Brown MS,Goldstein JL. Journal of Biological Chemistry . 1992
[6]
Dfferential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Su CY,Shiao MS,Wang CT. Biochemical Pharmacology . 1999
[7]
Les acides ganoderiques T à Z: triterpenes cytotoxiques de Ganoderma lucidum(Polyporacée). Toth JO,Luu Bang et Guy Ourisson. Tetrahedron Letters . 1983
[8]
Antinociceptive compinents of Ganoderma lucidum. Koyama K,Imaizumi T,Akiba M,et al. Planta Medica . 1997
[9]
Structures of ganoderic acid A and B, two new lanostane type bitter tritepenes from Ganoderma lucidum ( Fr. ) Karst. Kubota T,Asaka Y,Miura I,et al. Helv Chim Acta,1982, 65, Fasc .
[10]
Studies on the triterpenoid constituents of the spores from Ganoderma lucidum karst. Chen RY,Yu DQ. Acta Pharm Sin (药学学报) . 1991